Using Smart Technology to Improve Outcomes in Myocardial Infarction Patients: Rationale and Design of a Protocol for a Randomized Controlled Trial, The Box

Background Recent evidence suggests that frequent monitoring using smartphone-compatible wearable technologies might improve clinical effectiveness and patient satisfaction of care. Objective The aim of this study is to investigate the clinical effectiveness and patient satisfaction of a smart technology intervention in patients admitted with a ST elevation myocardial infarction (STEMI) or non-ST acute coronary syndrome (NST-ACS). Methods In this single center, open, randomized controlled trial patients who suffered from STEMI or NST-ACS will be randomized 1:1 to an intervention group or control group. Both groups will be followed up to one year after the index event. The intervention group will take daily measurements with a smartphone-compatible electrocardiogram device, blood pressure (BP) monitor, weight scale, and activity tracker. Furthermore, two of four outpatient clinic visits will be replaced by electronic visits (1 and 6 months after index event). The control group will receive regular care, consisting of four outpatient clinic visits (1, 3, 6, and 12 months after index event). All patients will be asked to fill in validated questionnaires about patient satisfaction, quality of life, propensity of medication adherence, and physical activity. Results The primary outcome of this trial will be percentage of patients with controlled BP. Secondary outcomes include patient satisfaction, health care utilization, major adverse cardiac events, medication adherence, physical activity, quality of life, and percentage of patients in which a sustained arrhythmia is detected. Conclusions Smart technology could potentially improve care in postmyocardial infarction patients. This trial will investigate whether usage of smart technology can improve clinical- and cost-effectiveness of care. Trial Registration Clinicaltrials.gov NCT02976376; https://clinicaltrials.gov/ct2/show/NCT02976376 (Archived by WebCite at http://www.webcitation.org/6tcvAdbdH)

[1]  J E Ware,et al.  Defining and measuring patient satisfaction with medical care. , 1983, Evaluation and program planning.

[2]  F. Rutten,et al.  UPDATE OF THE DUTCH MANUAL FOR COSTING IN ECONOMIC EVALUATIONS , 2012, International Journal of Technology Assessment in Health Care.

[3]  D. Atar,et al.  ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .

[4]  Lis Neubeck,et al.  iPhone ECG application for community screening to detect silent atrial fibrillation: a novel technology to prevent stroke. , 2013, International journal of cardiology.

[5]  H. Ward,et al.  Predictive Validity of a Medication Adherence Measure in an Outpatient Setting , 2008, Journal of clinical hypertension.

[6]  Jeroen J. Bax,et al.  MISSION!: optimization of acute and chronic care for patients with acute myocardial infarction. , 2007, American heart journal.

[7]  Praveen Raja,et al.  Effectiveness of Digital Medicines to Improve Clinical Outcomes in Patients with Uncontrolled Hypertension and Type 2 Diabetes: Prospective, Open-Label, Cluster-Randomized Pilot Clinical Trial , 2017, Journal of medical Internet research.

[8]  Juan Herrero,et al.  Internet Use and Self-Rated Health Among Older People: A National Survey , 2009, Journal of medical Internet research.

[9]  Yun-kai Zhai,et al.  Clinical- and Cost-effectiveness of Telemedicine in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis , 2014, Medicine.

[10]  B. Ainsworth,et al.  International physical activity questionnaire: 12-country reliability and validity. , 2003, Medicine and science in sports and exercise.

[11]  Jeroen J. Bax,et al.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.

[12]  Patrick J O'Connor,et al.  Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. , 2013, JAMA.

[13]  J. Brazier,et al.  The estimation of a preference-based measure of health from the SF-36. , 2002, Journal of health economics.

[14]  J. Kvedar,et al.  A randomized trial to evaluate the efficacy of online follow-up visits in the management of acne. , 2010, Archives of dermatology.

[15]  R. Redberg,et al.  Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions. , 2008, Archives of internal medicine.

[16]  D. Atsma,et al.  Redesigning healthcare: The 2.4 billion euro question? , 2016, Netherlands Heart Journal.

[17]  R. Thompson,et al.  Efficiency, satisfaction, and costs for remote video visits following radical prostatectomy: a randomized controlled trial. , 2015, European urology.

[18]  José Miguel Sotoca-Momblona,et al.  mHealth intervention to improve medication management in chronically ill patients: analysis of the recruitment process , 2016, Postgraduate medicine.

[19]  J. Ferrières,et al.  β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study , 2016, British Medical Journal.

[20]  J. E. Brazier,et al.  Validating the SF-36 health survey questionnaire: new outcome measure for primary care. , 1992, BMJ.

[21]  Julian Wienert,et al.  Effectiveness of a Web-Based Computer-Tailored Multiple-Lifestyle Intervention for People Interested in Reducing their Cardiovascular Risk: A Randomized Controlled Trial , 2016, Journal of medical Internet research.

[22]  R. Asmar,et al.  Validation of four devices: Omron M6 Comfort, Omron HEM-7420, Withings BP-800, and Polygreen KP-7670 for home blood pressure measurement according to the European Society of Hypertension International Protocol , 2014, Vascular health and risk management.

[23]  Jiajia Zhang,et al.  The systemic lupus erythematosus travel burden survey: baseline data among a South Carolina cohort , 2016, BMC Research Notes.